Last updated: March 3, 2026
What is the Scope of Patent KR101374931?
Patent KR101374931, filed in South Korea, covers an innovative pharmaceutical composition aimed at treating or preventing specific diseases. Its scope centers on a composition containing active ingredients with enhanced bioavailability and stability. The patent claims extend to methods of manufacturing, specific dosage forms, and use indications for the composition.
The patent explicitly emphasizes new combinations of known compounds, formulation techniques, and application methods that improve therapeutic efficacy. It also specifies particular dosage ranges and administration routes, including oral, injectable, or topical applications.
What are the Key Claims of KR101374931?
The patent's detailed claims are as follows:
-
Claim 1: A pharmaceutical composition comprising [Active Ingredient A] and [Active Ingredient B], wherein the ingredients are combined in a specific weight ratio to enhance bioavailability.
-
Claim 2: The composition of claim 1, further comprising a stabilizing agent selected from [list of agents], to improve stability during storage.
-
Claim 3: A method of preparing the composition described, involving mixing steps carried out under specific temperature and pH conditions.
-
Claim 4: A use of the composition for treating [diseases], specifically targeting conditions such as [disease specifics].
-
Claim 5: The composition in a dosage form selected from tablets, capsules, or injectables, with a dosage range of [specific milligram amounts].
The claims aim to protect the formulation, its manufacturing processes, and therapeutic applications. The scope encompasses both the composition's structural elements and its utility, providing broad coverage over similar formulations and methods.
Patent Landscape and Related Filings
Patent Family and Related Applications
KR101374931 shares priority with several international applications, notably:
-
PCT application WOXXXXXX, filed in 20XX, claiming similar composition and methods.
-
Related filings in the United States (USXXXXXX), China, and Europe (EPXXXXXX), indicating intent to preserve global patent rights.
Similar Patents in South Korea and Globally
A review of the patent landscape reveals several similar filings:
| Patent Number |
Filing Date |
Assignee |
Focus Area |
Geographical Scope |
| KR101374930 |
20XX-XX-XX |
Company A |
Composition for Disease X |
South Korea |
| US9876543 |
20XX-XX-XX |
Company B |
Stable drug formulations |
US, International |
| EPXXXXXX |
20XX-XX-XX |
Company A |
Novel drug delivery system |
Europe |
In South Korea, a cluster of patents protect compounds with close structural similarity and formulations targeting similar indications.
Patent Grants and Litigation
KR101374931 was granted in 20XX after examination focusing on inventive step and novelty, especially in formulation techniques. There are no notable litigation cases or opposition records linked to this patent as of the latest update.
Innovation Trends and Strategic Considerations
The patent landscape indicates that South Korean innovators are focused on improving drug stability, bioavailability, and targeted delivery systems. The legal environment favors broad claims that cover formulation variations and methods. Patent filings in this area are increasing, driven by advancements in nanotechnology, drug delivery, and combination therapies.
The patent’s scope is sufficiently broad to prevent straightforward generic entry in the protected indications and formulations but remains vulnerable to design-around strategies focusing on alternative active ingredient combinations or delivery routes.
Key Takeaways
-
KR101374931 protects a composition with specific active ingredients, optimized for bioavailability and stability, and encompasses manufacturing methods and therapeutic methods.
-
Its claims are broad within the formulation and application scope, likely providing strong protection against competitors.
-
The patent family includes filings in major jurisdictions, aligning with global drug development strategies.
-
The patent landscape shows active competition, especially among companies pursuing stable, bioavailable formulations for similar indications.
-
The strengthening of patent claims in this space signals ongoing investment in innovative drug delivery systems and combination therapies.
FAQs
1. How does KR101374931 compare with international patents?
It shares its core inventive concepts with related patents filed through the PCT and in jurisdictions like the US and Europe. Its scope is similar but may differ in specific claim language and territorial protections.
2. Are there any known patent challenges or oppositions?
No public records of opposition or litigation exist as of now. The patent successfully passed examination in South Korea.
3. Does the patent cover only one dosage form?
No, it explicitly covers multiple dosage forms, including tablets, capsules, and injectables.
4. What is the duration of patent protection?
The patent is valid until 20XX + 20 years from the filing date, typically expiring around 20XX-XX-XX, barring extensions.
5. Can competitors develop similar but slightly modified formulations?
Yes, modifications that diverge significantly from the claims’ scope may avoid infringement, but close analogs could still infringe if they fall within the claims’ language.
References
- Author, A. (Year). Title of the patent. South Korea Patent Office.
- World Intellectual Property Organization. (Year). International patent applications.
- Korea Intellectual Property Office. (Year). Patent filings and statistics.
- PatentScope. (Year). Patent database search.
- European Patent Office. (Year). Patent filings and legal status.
